Guanidinobenzamides as MC4-R agonists

Details for Australian Patent Application No. 2001288604 (hide)

International Classifications

Event Publications

1 May 2003 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 21 Mar 2003

24 February 2005 Application Accepted

Published as AU-B-2001288604

23 June 2005 Standard Patent Sealed

31 January 2008 Assignment Registered

Chiron Corporation The patent has been assigned to Novartis Vaccines and Diagnostic Inc.

24 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.